Literature DB >> 17925490

PGE2-induced metalloproteinase-9 is essential for dendritic cell migration.

Jui-Hung Yen1, Tanzilya Khayrullina, Doina Ganea.   

Abstract

Following antigen acquisition and maturation, dendritic cells (DCs) disengage from the extracellular matrix, cross basement membranes, and travel to draining lymph nodes to activate T cells. CCR7 expression is necessary but not sufficient for the directional migration of DCs. Prostaglandin E2 (PGE2), present in inflammatory sites, induces DC migration, presumably by enacting a migration-permissive gene expression program. Since regulation of DC migration is highly important for their use in vaccination and therapy, we examined the PGE2-induced changes in the expression of metalloproteinases (MMPs). Our results indicate that PGE2 significantly up-regulates MMP-9 expression, induces both secreted and membrane-bound MMP-9, and that in turn, DC-derived MMP-9 is essential for DC chemotaxis in response to the CCR7 ligand CCL19, Matrigel migration, and in vivo migration in both wild-type and MMP-9-deficient hosts. We conclude that DCs matured within inflammatory sites require both CCR7 and PGE2-induced MMP-9 for their directional migration to draining lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925490      PMCID: PMC2200811          DOI: 10.1182/blood-2007-05-090613

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed.

Authors:  Lorena Riol-Blanco; Noelia Sánchez-Sánchez; Ana Torres; Alberto Tejedor; Shuh Narumiya; Angel L Corbí; Paloma Sánchez-Mateos; José Luis Rodríguez-Fernández
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

2.  Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation.

Authors:  Y Kobayashi; M Matsumoto; M Kotani; T Makino
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

3.  Active matrix metalloprotease-9 in and migration pattern of dendritic cells matured in clinical grade culture conditions.

Authors:  Patrick Hollender; Danielle Ittelett; Florence Villard; Jean-Christophe Eymard; Pierre Jeannesson; Jacky Bernard
Journal:  Immunobiology       Date:  2002-10       Impact factor: 3.144

4.  Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta.

Authors:  E J Bartholomé; I Van Aelst; E Koyen; R Kiss; F Willems; M Goldman; G Opdenakker
Journal:  J Interferon Cytokine Res       Date:  2001-07       Impact factor: 2.607

5.  Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.

Authors:  Mathilde Kouwenhoven; Volkan Ozenci; Annelie Tjernlund; Mikhail Pashenkov; Mohammed Homman; Rayomand Press; Hans Link
Journal:  J Neuroimmunol       Date:  2002-05       Impact factor: 3.478

6.  Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin.

Authors:  Gudrun Ratzinger; Patrizia Stoitzner; Susanne Ebner; Manfred B Lutz; Guy T Layton; Christian Rainer; Robert M Senior; J Michael Shipley; Peter Fritsch; Gerold Schuler; Nikolaus Romani
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells.

Authors:  Nadège Noirey; Marie-Jeanne Staquet; Marie-Jo Gariazzo; Mireille Serres; Claude André; Daniel Schmitt; Claude Vincent
Journal:  Eur J Cell Biol       Date:  2002-07       Impact factor: 4.492

8.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.

Authors:  Thomas Luft; Michael Jefford; Petra Luetjens; Tracey Toy; Hubertus Hochrein; Kelly-Anne Masterman; Charlie Maliszewski; Ken Shortman; Jonathan Cebon; Eugene Maraskovsky
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

Authors:  Elke Scandella; Ying Men; Silke Gillessen; Reinhold Förster; Marcus Groettrup
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

10.  Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells.

Authors:  Kenji Kabashima; Daiji Sakata; Miyako Nagamachi; Yoshiki Miyachi; Kayo Inaba; Shuh Narumiya
Journal:  Nat Med       Date:  2003-05-12       Impact factor: 53.440

View more
  65 in total

1.  Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy.

Authors:  Carole Berger; Kristin Hoffmann; Juan G Vasquez; Shrikant Mane; Julia Lewis; Renata Filler; Aiping Lin; Hongyu Zhao; Tyler Durazzo; Abigail Baird; William Lin; Francine Foss; Inger Christensen; Michael Girardi; Robert Tigelaar; Richard Edelson
Journal:  Blood       Date:  2010-08-18       Impact factor: 22.113

2.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

3.  Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation.

Authors:  Jui-Hung Yen; Virginia P Kocieda; Huie Jing; Doina Ganea
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

4.  Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.

Authors:  Kirsten M Hooper; Jui-Hung Yen; Weimin Kong; Kate M Rahbari; Ping-Chang Kuo; Ana M Gamero; Doina Ganea
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

Review 5.  Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.

Authors:  Takefumi Inada; Kozue Kubo; Koh Shingu
Journal:  J Anesth       Date:  2011-05-25       Impact factor: 2.078

Review 6.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 7.  A two-step model for Langerhans cell migration to skin-draining LN.

Authors:  Eduardo J Villablanca; Jorge R Mora
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

8.  In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.

Authors:  Tanzilya Khayrullina; Jui-Hung Yen; Huie Jing; Doina Ganea
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta.

Authors:  Sung Ho Moon; Christopher M Jenkins; David J Mancuso; John Turk; Richard W Gross
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

Review 10.  Dendritic cells and liver fibrosis.

Authors:  Adeeb H Rahman; Costica Aloman
Journal:  Biochim Biophys Acta       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.